Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 (LODR) - Company Signed Contract To Supply 'WHIDENT' Range Of Toothpaste To North West African Cities

 We are pleased to announce that Company has signed a contract to supply 'WHIDENT' range of toothpaste to Casablanca, Morocco (North West Africa) as plan of expansion. Company has already been successfully manufacturing and exporting various types of toothpaste to East African countries. Company is expecting additional growth in sales in the current Financial Year with the new contract of supply & additional profit.
12-06-2023
Bigul

Veerhealth Care Limited - 511523 - Financial Results For March 31, 2023

 Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Statement showing the Audited Financial Results for the quarter and year ended March 31, 2023. 2. Auditors Report on the Audited Financial Results for the quarter and year ended March 31, 2023. 3. Declaration in respect of Audit Report with Unmodified Opinion.
22-05-2023
Bigul

Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. May 22, 2023 as under: 1. The Board has approved and taken on record the Audited Financial Results for the quarter and year ended March 31, 2023. 2. The Board has not recommended final dividend on equity shares of the Company for the financial year 2022-23. The Board Meeting commenced at 5.00 p.m. and concluded at 5.40 p.m.
22-05-2023
Bigul

Annual report for Veerhealth Care Ltd. for FY-2023
22-05-2023
Bigul

Veerhealth Care Limited - 511523 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we hereby submit Annual Secretarial Compliance Report for the financial year ended 31st March, 2023.
20-05-2023
Bigul

Veerhealth Care Limited - 511523 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2023 And Recommendation Of Dividend, If Any.

 Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 ,inter alia, to consider and approve the Audited Financial Results for the quarter and financial year ended 31st March, 2023 and recommendation of dividend, if any.
13-05-2023
Bigul

Veerhealth Care Limited - 511523 - Compliances-Statement Of Deviation Or Variation

 Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds of Preferential Issue from the objects stated in the Explanatory Statement to the Notice of Extra-Ordinary General Meeting of the Company dated 5th December, 2022. A statement confirming that there is no deviation or variation in the utilization of these proceeds is enclosed herewith.
28-04-2023
Bigul

Veerhealth Care Limited - 511523 - Compliances - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2023

 Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate submitted by M/s. Nidhi Shah & Associates, Practicing Company Secretary, for the year ended March 31, 2023.
19-04-2023
Bigul

Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 (LODR) - Permission Received For Disinfectant Manufacturing And In House Microbiology, Physical & Chemical Testing Laboratory At Our Vapi Factory

 We are pleased to announce that Company has decided to introduce new product line i.e. Disinfectant manufacturing. Company has received License (vide License No. G/25/2609 IN FORM NO. 25) to manufacture for sale (or for distribution) of drugs other than those specified in Schedules C, C(1) and X from the Food & Drugs Control Administration, Gujarat State. With this license, Company has also received approval for in house Microbiology, Physical & Chemical testing laboratory. Company is expecting growth in sales in the current Financial Year with the introduction of new Disinfectant category.
17-04-2023
Bigul

Veerhealth Care Limited - 511523 - Compliance Certificate For The Period Ended March 31, 2023

 Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate, duly signed by Share Transfer Agent and the Compliance Officer of the Company for the year ended March 31, 2023 in compliance of Regulation 7(2) of SEBI Listing Regulations, 2015.
07-04-2023
Next Page
Close

Let's Open Free Demat Account